SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Heartstream Inc. ( HTST )

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cheryl Galt who wrote (64)7/23/1997 5:40:00 PM
From: Cheryl Galt   of 97
 
Another good report, of a Mayo Clinic study.
Good press for HTST, to a target customer group
--- mid-year meeting of the National Association of Emergency Medical Services Physicians

" ... An abstract of this study [was] published by Dr. White in the July/September 1997 issue of Prehospital Emergency Care ..."

" ...The study reported by Dr. White is being conducted as part of a combined police/paramedic defibrillation program in Rochester, Minn., one of the first communities in the United States to train and equip police officers with AEDs. "

" ... For the past 30 years, such devices have delivered this energy using a monophasic waveform. In September 1996, the FDA cleared for marketing the Heartstream ForeRunner AED -- the ONLY external defibrillator commercially available in the US that uses biphasic waveform technology. "

biz.yahoo.com
------------------------------------------------------------------------------------------------

In my opinion, the product is the best, the market is there, and the word is getting out to the right professional audiences.
Investment in HTST is likely fairly speculative, but promising long-term.

Regards, Cheryl
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext